Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

The approvals mark the fourth and fifth clearances for Sanofi in the country in 2025. Credit: sylv1rob1/Shutterstock.com. China’s National Medical Products Administration (NMPA) has granted approval ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

(RTTNews) - Sanofi (SNY) announced the National Medical Products Administration in China has approved two Sanofi medicines for rare hematologic diseases: Qfitlia or fitusiran for hemophilia and ...

ZEISS Medical Technology announced today that China's National Medical Products Administration (NMPA) has approved the ZEISS ...

Stockholm, Sweden Tuesday, February 10, 2026, 14:00 Hrs [IST] ...

NTRK gene family fusions occur in less than 1% of all solid tumors, but represent one of the most actionable oncogenic alterations across cancer types. Patients harboring these fusions can benefit ...

(RTTNews) - Belite Bio Inc. (BLTE) announced that the Center for Drug Evaluation of China's National Medical Products Administration or NMPA has agreed to accept the New Drug Application with priority ...

The National Medical Products Administration (NMPA) has approved the OncoMate ® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China. It is ...

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow ...